What The Study Did: Researchers surveyed a large group of cancer survivors about their attitudes toward trial participation during the COVID-19 pandemic.
Authors: Mark E. Fleury, Ph.D., of the American Cancer Society Cancer Action Network in Washington, D.C., is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https:/
Editor's Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #Media advisory: The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https:/